This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Visual Overview
Abstract
Fibronectin-binding integrins α5β1 and αv collaborate in prostate cancer–bone stromal interactions relevant to the colonization of the bone marrow microenvironment. Combinatorial inactivation of these integrins on prostate cancer cells was assessed. Monospecific antibodies to α5β1and αv integrins alone (MAb) and in combination (cMAb), and a bispecific antibody that simultaneously targets α5β1and αv integrins (BsAbα5β1/αv) were compared in assays of chemotaxis, clonogenic survival, and induction of endothelial migration. Cellular expression of integrins, their transcription, translation, and degradation fate was compared. The BsAbα5β1/αv was superior to MAbs and cMAbs in abrogating adhesion, migration, clonogenic survival, and induction of endothelial migration responses by prostate cancer cells. Integrin upregulation observed with MAbs or cMAbs was abrogated with the BsAbα5β1/αv. Loss of integrin expression was uniquely induced by the BsAbα5β1/αv and blocked by lysosomal inhibition.
Implications: A novel and effective combinatorial strategy to target α5β1and αv integrins is defined for translational studies.
Visual Overview: http://mcr.aacrjournals.org/content/molcanres/18/1/27/F1.large.jpg.
Footnotes
Note: Supplementary data for this article are available at Molecular Cancer Research Online (http://mcr.aacrjournals.org/).
Mol Cancer Res 2020;18:27–32
- Received April 25, 2019.
- Revision received September 3, 2019.
- Accepted October 16, 2019.
- Published first October 21, 2019.
- Corrected online January 6, 2020.
- ©2019 American Association for Cancer Research.
Log in using your username and password
Purchase access
Volume 18, Issue 1
